| Literature DB >> 32192094 |
Michael Collins1, Murat Gel2, Chris Lennard1, Val Spikmans1, Shari Forbes3,4, Alisha Anderson5.
Abstract
The investigation of clandestine laboratories poses serious hazards for first responders, emergency services, investigators and the surrounding public due to the risk of exposure to volatile organic compounds (VOCs) used in the manufacture of illicit substances. A novel gas sampling interface using open microfluidic channels that enables the extraction of VOCs out of the gas phase and into a liquid, where it can be analysed by conventional detection systems, has recently been developed. This paper investigates the efficiency and effectiveness of such a gas-to-liquid (GTL) extraction system for the extraction of amphetamine-type substances (ATS) and their precursors from the vapour phase. The GTL interface was evaluated across a range of different ATS and their precursors (methamphetamine, dimethylamphetamine, N-formylmethamphetamine, benzaldehyde, phenyl-2-propanone, ephedrine and pseudoephedrine) at concentrations ranging between 10 and 32 mg m-3. These gas samples were produced by a gas generation system directly in Tedlar® bags and gas canisters for controlled volume sampling. When using gas sampled from Tedlar® bags, four of the seven compounds were able to be extracted by the GTL interface, with the majority of the VOCs having extraction yields between 0.005% and 4.5%, in line with the results from an initial study. When samples were taken from gas canisters, only benzaldehyde was able to be detected, with extraction efficiencies between 0.2% and 0.4%. A custom-built mount for the GTL interface helped to automate the extraction process, with the aim of increasing extraction efficiency or reducing variability. However, the extraction efficiency did not improve when using this accessory, but the procedure did become more efficient. The results from the study indicated that the GTL interface could be employed for the collection of gaseous ATS and incorporated into mobile detection systems for onsite collection and analysis of volatile compounds related to ATS manufacture.Entities:
Keywords: VOC; amphetamine; drug screening; gas-to-liquid extraction; microfluidic
Year: 2020 PMID: 32192094 PMCID: PMC7142577 DOI: 10.3390/mi11030315
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
Figure 1(a) Cross-section of a gas-to-liquid (GTL) interface showing 3 bonded layers. (b) Photo of the GTL interface with a solution of red food colouring dispersed throughout capillary channels, liquid ports (LPs) and gas ports (GPs). (c) Overhead image of hexagonal protrusions that form the capillary network. (d) Depth profile showing hexagonal protrusions beneath the red line (top) and 3D image (bottom) of the hexagonal protrusion network.
Figure 2Grey Innovation GTL interface mount: (a) overhead view showing a thermal bed (TB), a transparent saddle (TS), a pump (P) and a temperature controller (TC); (b) transparent saddle with a syringe barrel attached; and (c) microfluidic GTL interface mounted on the thermal bed.
Figure 3GTL extraction configuration of amphetamine-type substances (ATS) vapour: (a) prototype GTL mount showing the GTL interface in the thermal bed (TB) and fitted with septa (SE), syringes (SY), a pump (P) and a temperature controller (TC); and (b) Grey Innovation GTL mount showing the GTL Interface in the thermal bed (TB) fitted with a transparent saddle (TS), syringe barrels (SB) and a Tedlar® bag (TED) containing a gas sample.
GTL extraction of ATS and precursors using the prototype mount.
| Target Compound | ATS as Vapour (μg)1 | ATS Recovered (μg) | Concentration of GTL Extractions (μg mL–1) | Average Yield (%) | RSD of Replicates (%) | Vapour Pressure (mmHg at 25 °C) [ | GCMS LOD (μg mL–1) |
|---|---|---|---|---|---|---|---|
| Benzaldehyde | 100 | 5.2 | 52 | 5.2 | 31.4 | 1.2 | 5.05 |
| Phenyl-2-propanone | 40 | 3.6 | 36 | 9.1 | 26.2 | 0.2 | 2.4 |
| Methamphetamine | 140 | 1.9 | 19 | 1.3 | 45.6 | 0.005 | 3.1 |
| Dimethamphetamine | 140 | 2.1 | 21 | 1.5 | 42.4 | Data Not available | 5.5 |
| N-formylmethamphetamine | 120 | 0.05 | 0.5 | 0.04 | 15.8 | Data Not available | 3.1 |
| Ephedrine | 100 | Not detected | - | - | 0.001 | 6.9 | |
| Pseudoephedrine | 100 | Not detected | - | - | 0.0008 | 1.8 |
1 Maximum amount theoretically possible in a 300 mL sampling volume of the four compounds that were detected in the GTL extract.
GTL extraction of ATS and precursors using the Grey Innovation mount.
| Compound | ATS as Vapour (μg) | ATS Recovered (μg) | Concentration of GTL Extractions (μg mL–1) | Yield (%) | RSD of Replicates (%) |
|---|---|---|---|---|---|
| Benzaldehyde (1) | 100 | 2 | 20 | 2.0 | 28.0 |
| Benzaldehyde (2) | 100 | 4 | 40 | 3.7 | 48.9 |
| Phenyl-2-propanone (1) | 40 | 0.6 | 6 | 1.6 | 34.3 |
| Phenyl-2-propanone (2) | 40 | 0.6 | 6 | 1.6 | 25.4 |
GTL extraction of benzaldehyde in gas canisters using the prototype mount.
| Compound | ATS as Vapour (μg) | ATS Recovered (μg) | Concentration of GTL Extractions (μg mL–1) | Yield (%) | RSD of Replicates (%) |
|---|---|---|---|---|---|
| Benzaldehyde at day 1 | 30 | 0.3 | 3 | 0.1 | 28.6 |
| Benzaldehyde at day 2 | 30 | 0.02 | 0.2 | 0.05 | 18.8 |